CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0485
+0.0002 (0.31%)
Oct 3, 2025, 3:43 PM EDT
CV Sciences Market Cap
CV Sciences has a market cap or net worth of $8.94 million as of October 3, 2025. Its market cap has increased by 5.13% in one year.
Market Cap
8.94M
Enterprise Value
9.75M
Revenue
14.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since November 9, 2011, CV Sciences's market cap has increased from 3.71M to 8.94M, an increase of 140.88%. That is a compound annual growth rate of 6.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 8.94M | 43.49% |
| Dec 31, 2024 | 6.23M | 13.96% |
| Dec 29, 2023 | 5.47M | 10.51% |
| Dec 30, 2022 | 4.95M | -62.06% |
| Dec 31, 2021 | 13.04M | -72.32% |
| Dec 31, 2020 | 47.10M | -50.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |